EDESA BIOTECH, INC. Shareholders' Equity
EDESA BIOTECH, INC. (EDSA) had Shareholders' Equity of $8.81 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $8.81M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $10.20M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $13.95M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $12.45M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $8.81M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $10.20M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $13.95M 10-Q · filed 2026-05-14 | |
| 2025-09-30 | $12.45M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $14.13M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $15.54M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $2.26M 10-Q · filed 2026-05-14 | |
| 2024-09-30 | $1.98M 10-Q · filed 2026-08-13 | |
| 2024-06-30 | $2.87M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $4.32M 10-Q · filed 2025-08-08 | |
| 2023-12-31 | $5.84M 10-Q · filed 2025-05-14 | |
| 2023-09-30 | $7.05M 10-K · filed 2025-12-12 | |
| 2023-06-30 | $7.85M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $9.00M 10-Q · filed 2024-08-09 | |
| 2022-12-31 | $10.27M 10-Q · filed 2024-05-10 | |
| 2022-09-30 | $9.39M 10-K · filed 2024-12-13 | |
| 2022-06-30 | $11.84M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $17.02M 10-Q · filed 2023-08-09 | |
| 2021-12-31 | $10.55M 10-Q · filed 2023-05-11 | |
| 2021-09-30 | $13.06M 10-K · filed 2023-12-15 | |
| 2021-06-30 | $15.80M 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $19.27M 10-Q · filed 2022-08-12 | |
| 2020-12-31 | $7.89M 10-Q · filed 2022-05-13 | |
| 2020-09-30 | $6.63M 10-K · filed 2022-12-16 | |
| 2020-06-30 | $5.34M 10-Q · filed 2021-08-13 | |
| 2020-03-31 | $6.93M 10-Q · filed 2021-08-13 | |
| 2019-12-31 | $4.23M 10-Q · filed 2021-05-14 | |
| 2019-09-30 | $5.26M 10-K · filed 2021-12-28 | |
| 2019-06-30 | $6.21M 10-Q · filed 2020-08-12 | |
| 2019-03-31 | $2.77M 10-Q · filed 2020-08-12 | $8.27M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $3.21M 10-K · filed 2020-12-07 | $9.91M 10-Q · filed 2019-02-05 |
| 2018-09-30 | $3.55M 10-Q · filed 2020-08-12 | $11.29M 10-K · filed 2018-11-30 |
| 2018-06-30 | $12.39M 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $4.74M 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $5.00M 10-KT · filed 2019-12-12 | $6.02M 10-Q · filed 2018-02-07 |
| 2017-09-30 | $7.40M 10-Q · filed 2019-05-08 | |
| 2017-06-30 | $8.60M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $9.79M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $10.86M 10-Q · filed 2017-02-06 | |
| 2016-09-30 | $12.31M 10-K · filed 2018-11-30 | |
| 2016-06-30 | $7.66M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $8.81M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $9.63M 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $8.01M 10-K · filed 2017-12-01 | |
| 2015-06-30 | $9.43M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $8.92M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $9.24M 10-Q · filed 2015-02-09 | |
| 2014-09-30 | $10.46M 10-K · filed 2017-12-01 | |
| 2014-08-31 | $7.70M 10-K · filed 2016-12-14 | |
| 2013-09-30 | $6.54M 10-Q · filed 2015-02-09 | |
| 2013-08-31 | -$2.20M 10-K · filed 2016-12-14 | |
| 2012-08-31 | $902.16K 10-K · filed 2015-12-14 | |
| 2011-08-31 | $3.44M 10-K · filed 2014-11-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |